Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Oseltamivir 75 mg vs Tamiflu 75 mg in Healthy Volunteers
NCT02507648Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Mar 2013
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oseltamivir in influenza (2 arms), sponsored by Genuine Research Center. Primary endpoints: Bioequivalence of Oseltamivir vs Tamiflu, Maximum Plasma Concentration and 2 more. Started Mar 2013; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02507648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02507648.